Clinical and genomic characterization of ERBB2-altered gallbladder cancer.

被引：0
|
作者：
Mondaca, Sebastian
Schultz, Nikolaus
Roa, Juan Carlos
Walch, Henry S.
Sepulveda, Santiago
Harding, James J.
Yaqubie, Amin
Garcia, Patricia
Aguayo, Gloria
Nervi, Bruno
Li, Bob T.
Abou-Alfa, Ghassan K.
机构：
[1] Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Pathol, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Santiago, Chile
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[5] Pontificia Univ Catolica Chile, Dept Pathol, Santiago, Chile
[6] Hosp Dr Sotero del Rio, Dept Pathol, Santiago, Chile
[7] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[8] Cornell Univ, Weill Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4114
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical and Genomic Characterization of ERBB2-Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort
    Mondaca, Sebastian
    Walch, Henry
    Sepulveda, Santiago
    Schultz, Nikolaus
    Munoz, Gonzalo
    Yaqubie, Amin
    Macanas, Patricia
    Pareja, Claudia
    Garcia, Patricia
    Chatila, Walid
    Nervi, Bruno
    Li, Bob
    Harding, James J.
    Viviani, Paola
    Roa, Juan Carlos
    Abou-Alfa, Ghassan K.
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [2] Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer
    Leary, Jacob B.
    Enright, Thomas
    Bakaloudi, Dimitra Rafailia
    Basnet, Alina
    Bratslavsky, Gennady
    Jacob, Joseph
    Spiess, Philippe E.
    Li, Roger
    Necchi, Andrea
    Kamat, Ashish M.
    Pavlick, Dean C.
    Danziger, Natalie
    Huang, Richard S. P.
    Lin, Douglas I.
    Cheng, Liang
    Ross, Jeffrey
    Talukder, Rafee
    Grivas, Petros
    TARGETED ONCOLOGY, 2024, 19 (03) : 447 - 458
  • [3] Comprehensive characterization of ERBB2 genomic alterations inlung cancer.
    El Zarif, Talal
    Stockhammer, Paul
    Schillo, Jacob
    Goldberg, Sarah B.
    Politi, Katerina A.
    Grant, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Clinical and genomic landscape of ERBB2 and ERBB3 mutated breast cancer
    Bilani, Nadeem
    Tao, Jacqueline
    Safonov, Anton
    Casey, Dana
    Drago, Joshua
    Ahmed, Mehnaj
    Acevedo, Barbara
    Jhaveri, Komal
    Reis-Filho, Jorge
    Robson, Mark
    Toska, Eneda
    Hanker, Ariella
    Arteaga, Carlos
    Chandarlapaty, Sarat
    Wen, Hanna Y.
    Razavi, Pedram
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
    Chen, Jiayan
    Xu, Chunwei
    Wang, Qian
    Lv, Jiawen
    Lu, Wanjun
    Zhang, Yixue
    Yao, Yanwen
    Gu, Xiaoling
    Wu, Guannan
    Hao, Yue
    Pan, Weiwei
    Wang, Wenxian
    Zhang, Shirong
    Lv, Tangfeng
    Song, Yong
    Wang, Dong
    LUNG CANCER, 2023, 183
  • [6] Genomic alterations of ERBB receptors in cancer: clinical implications
    Mishra, Rosalin
    Hanker, Ariella B.
    Garrett, Joan T.
    ONCOTARGET, 2017, 8 (69) : 114371 - 114392
  • [7] Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers
    Zeme, Emily L.
    Van Loon, Katherine
    Kelley, Robin K.
    Gordan, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (27)
  • [8] Characterization of ERBB2 alterations in non-small cell lung cancer.
    Singh, Vijendra
    Feldman, Rebecca
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Vanderwalde, Ari M.
    Xiu, Joanne
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    Nagasaka, Misako
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Frequency and nature of genomic alterations (GA) in ERBB2altered urothelial bladder cancer (UBC)
    Talukder, R.
    Leary, J.
    Enright, T.
    Bakaloudi, D. R.
    Bratslavsky, G.
    Jacob, J. M.
    Spiess, P.
    Li, R.
    Necchi, A.
    Kamat, A.
    Pavlick, D. C.
    Danziger, N. A.
    Huang, R.
    Lin, D. I.
    Ross, J. S.
    Grivas, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S1221 - S1222
  • [10] Role of C-erbB2 expression in gallbladder cancer
    Kumari, Niraj
    Kapoor, V. K.
    Krishnani, Narendra
    Kumar, Kamlesh
    Baitha, Dinesh Kumar
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (01) : 75 - 79
12345